Kelly Chin, M.D. Titles and Appointments Medical Director, University Hospital Heart & Lung Clinic | Director, Pulmonary Clinical Research Unit Professor Schools Medical School Departments Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Kelly Chin, M.D., M.S.C.S., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Pulmonary and Critical Care Medicine. She serves as the Medical Director of the University Hospital Heart and Lung Clinic, and Director of the Pulmonary Clinical Research Unit. Dr. Chin holds a bachelor's degree with honors in biology from the University of Texas at Austin. She earned her medical degree and completed internal medicine residency training at UT Southwestern, followed by fellowship training in pulmonary and critical care medicine at the University of California San Diego. She also completed both a master's degree in clinical sciences with honors from UTSW through the UT Southwestern Clinical Scholar's Program. She is currently serving as Director of Pulmonary Hypertension Research. She previously served as the Director of the UTSW Pulmonary Hypertension Program from 2010-2023. Dr. Chin joined the UT Southwestern faculty in 2005. Her clinical interests include pulmonary hypertension and chronic thromboembolic hypertension, and she has served as a principal investigator and as a steering committee member for multiple phase II, III and IV clinical trials in pulmonary hypertension. She frequently investigates how therapies affect heart structure and function, how different patient subgroups respond to treatment, and how certain drugs can change the course of disease. Her research also highlights challenges such as stimulant‑associated pulmonary arterial hypertension, pulmonary hypertension in connective tissue disease, chronic thromboembolic pulmonary hypertension, and the complications patients face as the disease progresses. Across her scientific contributions and invited lectures, Dr. Chin has consistently aimed to refine treatment algorithms, expand therapeutic options, and improve quality of life and survival for people living with pulmonary hypertension. Dr. Chin is an active member of several professional organizations, including the American Thoracic Society, Pulmonary Hypertension Association, American College of Chest Physicians, and the American Heart Association. Education Medical Education UT Southwestern Medical School (1996), Doctor of Medicine Residency UT Southwestern Medical Center (2000), Internal Medicine Fellowship University of California at San Diego School of Medicine (2005), Pulmonary Diseases & Critical Care Medicine Research Interest Pulmonary Hypertension Publications Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction Sarma S, Chin KM Circulation 2026 May 153 1460-1462 Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period Ford HJ, Chin KM, Fan F, Friberg M, Grünig E, Hauser JA, Pannaux M, Rofael H, Jansa P Advances in Therapy 2026 May 43 2106-2124 Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies) Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH Drugs - Real World Outcomes 2026 Mar 13 85-100 Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies Melendres-Groves LD, Channick RN, Chin KM, McLaughlin VV, MacDonald G, Martin N, Ong R, Sandros M, Kim NH Advances in Therapy 2026 Jan 43 231-254 Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study Howard LS, Kiely DG, Lawrie A, Maron BA, Preston IR, Rosenkranz S, Toshner M, Wilkins MR, Fong YL, Quinn D, Stamatiadis D, Villeneuve M, Chin KM Pulmonary Circulation 2026 Jan 16 Preferences for pulmonary arterial hypertension (PAH) medications: plain language summary on insights from interviews with patients and doctors in the A DUE phase 3 clinical study Fan F, Davis S, Burbridge C, Chin K, Friberg M, Grünig E, Hughes M, Jansa P, Langan G, Linder J, Rafalski J, Rodriguez AA, Randall JA Future Cardiology 2026 22 11-22 Long-term safety and tolerability of frespaciguat: the INSIGNIA-PAH extension Humbert M, Hassoun PM, Chin KM, Bortman G, Garcia-Aguilar H, Rosa CL, Ford M, Fu W, Niu PY, Loureiro MJ, Hoeper MM European Respiratory Journal 2026 67 How to Care for the Patient With Methamphetamine-Associated Pulmonary Arterial Hypertension Kolaitis NA, Barnett CF, Chin KM, Clapham K, Incze MA, Kennedy AJ, Kingrey JF, Matusov Y, Melendres-Groves L, Rischard FP, Simon MA CHEST 2026 Critical Results Notification System in the Electronic Health Record: Advancing Radiology and Patient Care Garduno-Rapp NE, Ng YS, Willett D, McDonald S, Balani J, Thomas A, Vagefi PA, Patel S, Cheruku S, Chin K, Lee F, Espino A, Luedtke K, Glazer C, Zeikus E Academic radiology 2025 Nov 32 6422-6432 Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study Author Collaboration tT, Sitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS Advances in Therapy 2025 Oct 42 5104-5123 Results 1-10 of 97 1 2 3 4 5 Next Last Books Featured Books Pulmonary Hypertension. In Murray and Nadel's Textbook of Respiratory Medicine Chin KM, Channick RN. (2022). Chronic Thromboembolic Pulmonary Hypertension. In Pulmonary Vascular Disease Chin K, Fedullo P. (2006). Surgical Treatments. In Pulmonary Hypertension. A Patient's Survival Guide Chin KM, Torres F (2011). Honors & Awards Finalist, Alfred Soffer Research AwardACCP Original Research Award 2007 Southwestern Medical Foundation Medical School Scholarship UT Southwestern Clinical Scholar, Class of 2011 Professional Associations/Affiliations American College of Chest Physicians American Medical Association American Thoracic Society Pulmonary Hypertension Association
